Tag archive for ‘Michael Hayden’

Teva buys 51% stake in Genomic-Analysis Company Immuneering for $60 million

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has announced the acquisition of 51% of Immuneering Corporation, a privately-held genomic-analysis company based in Cambrige, Massachusetts. More...

Jewish Business News Correspondent On Thursday, September 11th, 2014

Teva finds double-dose Copaxone halves side-effects

– A 50% reduction in adverse side-effects was reported with the three-times-a-week 40 mg MS injection. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has published results More...

Teva Reports Positive Phase III Asthma Drug Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported that asthma treatment reslizumab demonstrated clear levels of efficacy in achieving the primary endpoint of reduction in the frequency More...

Wordpress site Developed by Fixing WordPress Problems